Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q86UP6 (
CUB and zona pellucida-like domain-containing protein 1
)
8
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In the mammary gland, genetic circuits controlled by estrogen, progesterone, and prolactin, act in concert with pathways regulated by members of the epidermal growth factor family to orchestrate growth and morphogenesis during puberty, pregnancy and lactation. However, the precise mechanisms underlying the crosstalk between the hormonal and growth factor pathways remain poorly understood. We have identified the
CUB and zona pellucida-like domain-containing protein 1
(
CUZD1
), expressed in mammary ductal and alveolar epithelium, as a novel mediator of mammary gland proliferation and differentiation during pregnancy and lactation. Cuzd1-null mice exhibited a striking impairment in mammary ductal branching and alveolar development during pregnancy, resulting in a subsequent defect in lactation. Gene expression profiling of mammary epithelium revealed that
CUZD1
regulates the expression of a subset of the EGF family growth factors, epiregulin, neuregulin-1, and epigen, which act in an autocrine fashion to activate ErbB1 and ErbB4 receptors. Proteomic studies further revealed that
CUZD1
interacts with a complex containing JAK1/JAK2 and
STAT5
, downstream transducers of prolactin signaling in the mammary gland. In the absence of
CUZD1
,
STAT5
phosphorylation in the mammary epithelium during alveologenesis was abolished. Conversely, elevated expression of Cuzd1 in mammary epithelial cells stimulated prolactin-induced phosphorylation and nuclear translocation of
STAT5
. Chromatin immunoprecipitation confirmed co-occupancy of phosphorylated
STAT5
and
CUZD1
in the regulatory regions of epiregulin, a potential regulator of epithelial proliferation, and whey acidic protein, a marker of epithelial differentiation. Collectively, these findings suggest that
CUZD1
plays a critical role in prolactin-induced JAK/
STAT5
signaling that controls the expression of key
STAT5
target genes involved in mammary epithelial proliferation and differentiation during alveolar development.
...
PMID:CUZD1 is a critical mediator of the JAK/STAT5 signaling pathway that controls mammary gland development during pregnancy. 2827 76
The peptide hormone prolactin (PRL) and certain members of the epidermal growth factor (EGF) family play central roles in mammary gland development and physiology, and their dysregulation has been implicated in mammary tumorigenesis. Our recent studies have revealed that the
CUB and zona pellucida-like domain-containing protein 1
(
CUZD1
) is a critical factor for PRL-mediated activation of the transcription factor
STAT5
in mouse mammary epithelium. Of note,
CUZD1
controls production of a specific subset of the EGF family growth factors and consequent activation of their receptors. Here, we found that consistent with this finding,
CUZD1
overexpression in non-transformed mammary epithelial HC11 cells increases their proliferation and induces tumorigenic characteristics in these cells. When introduced orthotopically in mouse mammary glands, these cells formed adenocarcinomas, exhibiting elevated levels of
STAT5
phosphorylation and activation of the EGF signaling pathway. Selective blockade of
STAT5
phosphorylation by pimozide, a small-molecule inhibitor, markedly reduced the production of the EGF family growth factors and inhibited PRL-induced tumor cell proliferation
in vitro
Pimozide administration to mice also suppressed
CUZD1
-driven mammary tumorigenesis
in vivo
Analysis of human MCF7 breast cancer cells indicated that
CUZD1
controls the production of the same subset of EGF family members in these cells as in the mouse. Moreover, pimozide treatment reduced the proliferation of these cancer cells. Collectively, these findings indicate that overexpression of
CUZD1
, a regulator of growth factor pathways controlled by PRL and
STAT5
, promotes mammary tumorigenesis. Blockade of the
STAT5
signaling pathway downstream of
CUZD1
may offer a therapeutic strategy for managing these breast tumors.
...
PMID:Aberrantly high expression of the CUB and zona pellucida-like domain-containing protein 1 (CUZD1) in mammary epithelium leads to breast tumorigenesis. 2932 Dec 7